|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
El-Serag HB: Hepatocellular carcinoma. N
Engl J Med. 365:1118–1127. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sarasin FP, Giostra E and Hadengue A:
Cost-effectiveness of screening for detection of small
hepatocellular carcinoma in western patients with Child-Pugh class
A cirrhosis. Am J Med. 101:422–434. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cervello M, McCubrey JA, Cusimano A,
Lampiasi N, Azzolina A and Montalto G: Targeted therapy for
hepatocellular carcinoma: Novel agents on the horizon. Oncotarget.
3:236–260. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lin PT, Gleeson JG, Corbo JC, Flanagan L
and Walsh CA: DCAMKL1 encodes a protein kinase with homology to
doublecortin that regulates microtubule polymerization. J Neurosci.
20:9152–9161. 2000.PubMed/NCBI
|
|
6
|
Ohmae S, Takemoto-Kimura S, Okamura M,
Adachi-Morishima A, Nonaka M, Fuse T, Kida S, Tanji M, Furuyashiki
T, Arakawa Y, et al: Molecular identification and characterization
of a family of kinases with homology to Ca2+/calmodulin-dependent
protein kinases I/IV. J Biol Chem. 281:20427–20439. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Giannakis M, Stappenbeck TS, Mills JC,
Leip DG, Lovett M, Clifton SW, Ippolito JE, Glasscock JI, Arumugam
M, Brent MR and Gordon JI: Molecular properties of adult mouse
gastric and intestinal epithelial progenitors in their niches. J
Biol Chem. 281:11292–11300. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
May R, Riehl TE, Hunt C, Sureban SM, Anant
S and Houchen CW: Identification of a novel putative
gastrointestinal stem cell and adenoma stem cell marker,
doublecortin and CaM kinase-like-1, following radiation injury and
in adenomatous polyposis coli/multiple intestinal neoplasia mice.
Stem Cells. 26:630–637. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nakanishi Y, Seno H, Fukuoka A, Ueo T,
Yamaga Y, Maruno T, Nakanishi N, Kanda K, Komekado H, Kawada M, et
al: Dclk1 distinguishes between tumor and normal stem cells in the
intestine. Nat Genet. 45:98–103. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Westphalen CB, Asfaha S, Hayakawa Y,
Takemoto Y, Lukin DJ, Nuber AH, Brandtner A, Setlik W, Remotti H,
Muley A, et al: Long-lived intestinal tuft cells serve as colon
cancer-initiating cells. J Clin Invest. 124:1283–1295. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Westphalen CB, Quante M, Worthley D,
Asfaha S, Remotti H, Olive KP and Wang TC: Dclk1 labels quiescent
pancreatic progenitor and cancer initiating cells. Cancer Res. 72
Suppl:Abstract 5220. 2012. View Article : Google Scholar
|
|
12
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 100:pp.
3983–3988. 2003, View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li C, Heidt DG, Dalerba P, Burant CF,
Zhang L, Adsy V, Wicha M, Clarke MF and Simeone DM: Identification
of pancreatic cancer stem cells. Cancer Res. 67:1030–1037. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mishra L, Banker T, Murray J, Byers S,
Thenappan A, He AR, Shetty K, Johnson L and Reddy EP: Liver stem
cells and hepatocellular carcinoma. Hepatology. 49:318–329. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lobo NA, Shimono Y, Qian D and Clarke MF:
The biology of cancer stem cells. Annu Rev Cell Dev Biol.
23:675–699. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Singh SK, Hawkins C, Clarke ID, Squire JA,
Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB:
Identification of human brain tumor initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Diehn M and Clarke MF: Cancer stem cells
and radiotherapy: New insights into tumor radioresistance. J Natl
Cancer Inst. 98:1755–1757. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tang C, Ang BT and Pervaiz S: Cancer stem
cell: Target for anti-cancer therapy. FASEB J. 21:3777–3785. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sureban SM, May R, Lightfoot SA, Hoskins
AB, Lerner M, Brackett DJ, Postier RG, Ramanujam R, Mohammed A, Rao
CV, et al: DCAMKL-1 regulates epithelial-mesenchymal transition in
human pancreatic cells through a miR-200a-dependent mechanism.
Cancer Res. 71:2328–2338. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sureban SM, May R, Mondalek FG, Qu D,
Ponnurangam S, Pantazis P, Anant S, Ramanujam RP and Houchen CW:
Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144
and inhibits colorectal cancer tumor growth via a Notch-1 dependent
mechanism. J Nanobiotechnology. 9:402011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sureban SM, May R, Qu D, Weygant N,
Chandrakesan P, Ali N, Lightfoot SA, Pantazis P, Rao CV, Postier RG
and Houchen CW: DCLK1 regulates pluripotency and angiogenic factors
via microRNA-dependent mechanisms in pancreatic cancer. PLoS One.
8:e739402013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sureban SM, May R, Ramalingam S,
Subramaniam D, Natarajan G, Anant S and Houchen CW: Selective
blockade of DCAMKL-1 results in tumor growth arrest by a Let-7a
MicroRNA-dependent mechanism. Gastroenterology. 137(649–659): e1–2.
2009.
|
|
24
|
Sureban SM, May R, Weygant N, Qu D,
Chandrakesan P, Bannerman-Menson E, Ali N, Pantazis P, Westphalen
CB, Wang TC and Houchen CW: XMD8-92 inhibits pancreatic tumor
xenograft growth via a DCLK1-dependent mechanism. Cancer Lett.
351:151–161. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ali N, Allam H, May R, Sureban SM, Bronze
MS, Bader T, Umar S, Anant S and Houchen CW: Hepatitis C
virus-induced cancer stem cell-like signatures in cell culture and
murine tumor xenografts. J Virol. 85:12292–12303. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
May R, Sureban SM, Hoang N, Riehl TE,
Lightfoot SA, Ramanujam R, Wyche JH, Anant S and Houchen CW:
Doublecortin and CaM kinase-like-1 and
leucine-rich-repeat-containing G-protein-coupled receptor mark
quiescent and cycling intestinal stem cells, respectively. Stem
Cells. 27:2571–2579. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gagliardi G, Goswami M, Passera R and
Bellows CF: DCLK1 immunoreactivity in colorectal neoplasia. Clin
Exp Gastroenterol. 5:35–42. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Saqui-Salces M, Keeley TM, Grosse AS, Qiao
XT, EL-Zaatari M, Gumucio DL, Samuelson LC and Merchant JL: Gastric
tuft cells express DCLK1 and are expanded in hyperplasia. Histochem
Cell Biol. 136:191–204. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ikezono Y, Koga H, Abe M, Akiba J,
Kawahara A, Yoshida T, Nakamura T, Iwamoto H, Yano H, Kage M, et
al: High expression of the putative cancer stem cell marker, DCLK1,
in rectal neuroendocrine tumors. Oncol Lett. 10:2015–2020.
2015.PubMed/NCBI
|
|
30
|
Hao XP, Willis JE, Pretlow TG, Rao JS,
MacLennan GT, Talbot IC and Pretlow TP: Loss of fragile histidine
triad expression in colorectal carcinomas and premalignant lesions.
Cancer Res. 60:18–21. 2000.PubMed/NCBI
|
|
31
|
Sureban SM, Madhoun MF, May R, Qu D, Ali
N, Fazili J, Weygant N, Chandrakesan P, Ding K, Lightfoot SA and
Houchen CW: Plasma DCLK1 is a marker of hepatocellular carcinoma
(HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a
microRNA-dependent mechanism. Oncotarget. 6:37200–37215. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fattovivh G, Stroffoloni T, Zagni I and
Donato F: Hepatocellular carcinoma in cirrhosis: Incidence and risk
factors. Gastroenterology. 127 5 Suppl 1:S35–S50. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Torzilli G, Belghiti J, Kokudo N, Takayama
T, Capussotti L, Nuzzo G, Vauthey JN, Choti MA, De Santibanes E,
Donadon M, et al: A snapshot of the effective indications and
results of surgery for hepatocellular carcinoma in tertiary
referral centers: Is it adherent to the EASL/AASLD recommendations?
An observational study of the HCC East-West study group. Ann Sugr.
257:929–937. 2013. View Article : Google Scholar
|
|
34
|
Fan ST, Poon RT, Yeung C, Lam CM, Lo CM,
Yuen WK, Ng KK, Liu CL and Chan SC: Outcome after partial
hepatectomy for hepatocellular cancer within the Milan criteria. Br
J Surg. 98:1292–1300. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
O'Connell MR, Sarkar S, Luthra GK, Okugawa
Y, Toiyama Y, Gajjar AH, Qiu S, Goel A and Singh P: Epigenetic
changes and alternate promoter usage by human colon cancers for
expressing DCLK1-isoforms: Clinical Implications. Sci Rep.
5:149832015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Meng QB, Yu JC, Kang WM, Ma ZQ, Zhou WX,
Li J, Zhou L, Cao ZJ and Tian SB: Expression of doublecortin-like
kinase 1 in human gastric cancer and its correlation with
prognosis. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 35:639–644.
2013.(In Chinese). PubMed/NCBI
|
|
37
|
Reiner O, Coquelle FM, Peter B, Levy T,
Kaplan A, Sapir T, Orr I, Barkai N, Eichele G and Bergmann S: The
evolving doublecortin (DCX) superfamily. BMC Genomics. 7:1882006.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lin PT, Gleeson JG, Corbo JC, Flanagan L
and Walsh CA: DCAMKL1 encodes a protein kinase with homology to
doublecortin that regulates microtubule polymerization. J Neurosci.
20:9152–9161. 2000.PubMed/NCBI
|
|
39
|
Koizumi H, Tanaka T and Gleeson JG:
Doublecortin-like kinase functions with doublecortin to mediate
fiber tract decussation and neuronal migration. Neuron. 49:55–66.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gleeson JG, Minnerath SR, Fox JW, Allen
KM, Luo RF, Hong SE, Berg MJ, Kuzniecky R, Reitnauer PJ, Borgatti
R, et al: Characterization of mutations in the gene doublecortin in
patients with double cortex syndrome. Ann Neurol. 45:146–153. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gleeson JG, Lin PT, Flanagan LA and Walsh
CA: Doublecortin is a microtubule-associated protein and is
expressed widely by migrating neurons. Neuron. 23:257–271. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Schaar BT, Kinoshita K and McConnell SK:
Doublecortin microtubule affinity is regulated by a balance of
kinase and phosphatase activity at the leading edge of migrating
neurons. Neuron. 41:203–213. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Clark EA, Golub TR, Lander ES and Hynes
RO: Genomic analysis of metastasis reveals an essential role for
RhoC. Nature. 406:532–535. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
McManus MT: MicroRNAs and cancer. Semin
Cancer Biol. 13:253–258. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Takamizawa J, Konishi H, Yanagisawa K,
Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y,
et al: Reduced expression of the let-7 microRNAs in human lung
cancers in association with shortened postoperative survival.
Cancer Res. 64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Turley EA, Veiseh M, Radisky DC and
Bissell MJ: Mechanisms of disease: Epithelial-mesenchymal
transition-does cellular plasticity fuel neoplastic progression?
Nat Clin Pract Oncol. 5:280–290. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Diehn M and Clarke MF: Cancer stem cells
and radiotherapy: New insights into tumor radioresistance. J Natl
Cancer Inst. 98:1755–1757. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Xu N, Papagiannakopoulos T, Pan G, Thomson
JA and Kosik KS: MicroRNA-145 regulates OCT4, SOX2, and KLF4 and
represses pluripotency in human embryonic stem cells. Cell.
137:647–658. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yamashita T and Wang XW: Cancer stem cells
in the development of liver cancer. J Clin Invest. 123:1911–1918.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ali N, Chandrakesan P, Nguyen CB, Husain
S, Gillaspy AF, Huycke M, Berry WL, May R, Qu D, Weygant N, et al:
Inflammatory and oncogenic roles of a tumor stem cell marker
doublecortin-like kinase (DCLK1) in virus-induced chronic liver
diseases. Oncotaarget. 6:20327–20344. 2015. View Article : Google Scholar
|
|
51
|
Lata J: Chronic liver diseases as liver
tumor precursors. Dig Dis. 28:596–599. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ito H, Tanaka S, Akiyama Y, Shimada S,
Adikrisna R, Matsumura S, Aihara A, Mitsunori Y, Ban D, Ochiai T,
et al: Dominant expression of DCLK1 in human pancreatic cancer stem
cells accelerates tumor invasion and metastasis. PLoS One.
11:e01465642016. View Article : Google Scholar : PubMed/NCBI
|
